 Nanoparticles hold great promise in combating the COVID-19 pandemic through vaccine-based prevention, early detection, targeted treatment, and addressing emerging clinical problems such as reinfection, pregnancy-related COVID-19, and co-infection. This article was authored by Aleksandra Squarek, Aleksandra Goseca, Miloš J. Jagacyski and others.